Good evening :)
$
₹
Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

TNDM

NASDAQ
Asset Logo

Tandem Diabetes Care Inc

TNDM

NASDAQ
$20.050.77% (+0.15)
$
₹
$20.050.77% (+0.15)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Small Cap

With a market cap of $1.4B the stock is ranked 2532

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

10.89
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.9
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-6.08%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 21 analysts' reports

Buy
10 analysts
Hold
10 analysts
Sell
1 analyst

Analysts expect a +44.22% price upside over the next year

Current Price$20.05
Target Price$28.7

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
35.05
35.05
1Y Return
18.06%
18.06%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.61
37.61
1Y Return
4.52%
4.52%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
42.00
42.00
1Y Return
19.32%
19.32%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
23.19
23.19
1Y Return
2.19%
2.19%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
31.44
31.44
1Y Return
22.95%
22.95%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Tandem Diabetes Care Inc -10.890
Abbott Laboratories35.053.681.99
Danaher Corporation37.612.821.26

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

249.2
-21.1
290.3
-0.5
247.2
-20.3
254.5
-21.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue191.67221.91363.28282.64234.42240.67249.25290.38247.22254.56
Net Income-42.71-30.81-23.250.75-130.55-52.4-21.16-0.58-20.39-21.16
Net Profit Margin-22.28%-13.88%-6.40%0.26%-55.69%-21.77%-8.49%-0.20%-8.24%-8.31%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Tandem Diabetes Care Inc (TNDM) share price today is $20.05 as of September 8, 2026 at 9:51 PM IST. The stock touched a day high of $20.50 and a day low of $19.50.

  2. Tandem Diabetes Care Inc stock trades on NASDAQ under the ticker symbol TNDM.

  3. Tandem Diabetes Care Inc's market capitalization is $1.38B as of September 8, 2026 at 9:51 PM IST.

  4. Tandem Diabetes Care Inc's price-to-earnings (P/E) ratio is N/A as of September 8, 2026.

  5. Tandem Diabetes Care Inc's price-to-book (P/B) ratio is 10.89 as of September 8, 2026.

  6. Yes, You can buy Tandem Diabetes Care Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Tandem Diabetes Care Inc shares in three steps: 1. Search Tandem Diabetes Care Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Tandem Diabetes Care Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Tandem Diabetes Care Inc (TNDM) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4986 shares at the current price of $20.05.

Loading...